Closing Bell: Hls Therapeutics Inc down on Thursday (HLS)

In today's trading, Hls Therapeutics Inc shares closed at $3.14 after opening the day at $3.14. prices ranged from a low of $3.14 to a high of $3.14.

Shares dipped -3.09% from the previous day's close of $3.24.

Today across North America, the TSX Composite closed -0.14% at 22608.03, the S&P 500 closed -2.31% at 5427.13, the Dow Jones Industrial Average closed -1.25% at 39853.87 and the Nasdaq Composite closed -3.64% at 17342.41.

Hls Therapeutics Inc traded under HLS on the Toronto Stock Exchange (TSX).

Trading volume was 300 on 3 total trades. On average, Hls Therapeutics Inc has traded 97,544 shares over the last 5-days and 11,020 year-to-date.

Trading across the entire TSX saw 3,490 price advancers against 1,736 declines and 92 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $6.40 (July 26,2023) and low as $3.07 (July 24,2024). Moreover, in the last 12 months, Hls Therapeutics Inc's shares have shrunken -49.44 percent, while this year, they have dipped -20.51%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $103.08 million on a float of 31,815 shares outstanding. Its annual EPS is $-0.86.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc is holding an average recommendation of "Moderate Buy" from 5.00 analysts according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..